 | KMK | 表記: | methyl 1-[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-(3-oxidanylpropyl)amino]phenyl]carbonylpiperidine-4-carboxylate | 組成式: | C24 H30 N8 O4 | SMILES: | COC(=O)C1CCN(CC1)C(=O)c2ccc(cc2)N(CCCO)Cc3cnc4nc(N)nc(N)c4n3 | InChi: | InChI=1S/C24H30N8O4/c1-36-23(35)16-7-10-31(11-8-16)22(34)15-3-5-18(6-4-15)32(9-2-12-33)14-17-13-27-21-19(28-17)20(25)29-24(26)30-21/h3-6,13,16,33H,2,7-12,14H2,1H3,(H4,25,26,27,29,30) | 定義日: | 2019-06-07 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | methyl 1-[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-(3-oxidanylpropyl)amino]phenyl]carbonylpiperidine-4-carboxylate |
|
 | KMW | 表記: | 3-(4-aminocarbonylphenoxy)benzamide | 組成式: | C14 H12 N2 O3 | SMILES: | NC(=O)c1ccc(Oc2cccc(c2)C(N)=O)cc1 | InChi: | InChI=1S/C14H12N2O3/c15-13(17)9-4-6-11(7-5-9)19-12-3-1-2-10(8-12)14(16)18/h1-8H,(H2,15,17)(H2,16,18) | 定義日: | 2019-06-10 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 3-(4-aminocarbonylphenoxy)benzamide |
|
 | N9W | 表記: | 4-[(2-methyl-3,4-dihydro-1~{H}-pyrido[4,3-b]indol-5-yl)methyl]-~{N}-oxidanyl-benzamide | 組成式: | C20 H21 N3 O2 | SMILES: | CN1CCc2n(Cc3ccc(cc3)C(=O)NO)c4ccccc4c2C1 | InChi: | InChI=1S/C20H21N3O2/c1-22-11-10-19-17(13-22)16-4-2-3-5-18(16)23(19)12-14-6-8-15(9-7-14)20(24)21-25/h2-9,25H,10-13H2,1H3,(H,21,24) | 定義日: | 2019-11-21 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 4-[(2-methyl-3,4-dihydro-1~{H}-pyrido[4,3-b]indol-5-yl)methyl]-~{N}-oxidanyl-benzamide |
|
 | JHC | 表記: | [(2S)-2-[(2S)-butan-2-yl]-4-(5-chloro-1,3-benzoxazol-2-yl)-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone | 組成式: | C26 H29 Cl N6 O2 | SMILES: | N3(c2oc1c(cc(cc1)Cl)n2)CC(C(CC)C)N(CCC3)C(=O)c4c(ccc(c4)C)n5nccn5 | InChi: | InChI=1S/C26H29ClN6O2/c1-4-18(3)23-16-31(26-30-21-15-19(27)7-9-24(21)35-26)12-5-13-32(23)25(34)20-14-17(2)6-8-22(20)33-28-10-11-29-33/h6-11,14-15,18,23H,4-5,12-13,16H2,1-3H3/t18-,23+/m0/s1 | 定義日: | 2019-12-20 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | [(2S)-2-[(2S)-butan-2-yl]-4-(5-chloro-1,3-benzoxazol-2-yl)-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone |
|
 | L4B | 表記: | (4~{a}~{R},4~{b}~{S},6~{a}~{R},11~{a}~{R},11~{b}~{S},13~{a}~{R})-1,1,4~{a},6~{a},11~{b}-pentamethyl-9,10-bis(oxidanyl)-
3,4,4~{b},5,6,11,11~{a},12,13,13~{a}-decahydro-2~{H}-indeno[2,1-a]phenanthrene-7-carboxylic acid | 組成式: | C27 H38 O4 | SMILES: | CC1(C)CCC[C]2(C)[CH]1CC[C]3(C)[CH]2CC[C]4(C)[CH]3Cc5c(O)c(O)cc(C(O)=O)c45 | InChi: | InChI=1S/C27H38O4/c1-24(2)9-6-10-25(3)18(24)7-11-26(4)19(25)8-12-27(5)20(26)14-15-21(27)16(23(30)31)13-17(28)22(15)29/h13,18-20,28-29H,6-12,14H2,1-5H3,(H,30,31)/t18-,19+,20-,25-,26+,27-/m1/s1 | 別名: | merosterolic acid A | 定義日: | 2019-07-19 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | (4~{a}~{R},4~{b}~{S},6~{a}~{R},11~{a}~{R},11~{b}~{S},13~{a}~{R})-1,1,4~{a},6~{a},11~{b}-pentamethyl-9,10-bis(oxidanyl)-3,4,4~{b},5,6,11,11~{a},12,13,13~{a}-decahydro-2~{H}-indeno[2,1-a]phenanthrene-7-carboxylic acid |
|
 | L4E | 表記: | geranylgeranyl dihydroxybenzoate | 組成式: | C27 H38 O4 | SMILES: | CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCc1cc(cc(O)c1O)C(O)=O | InChi: | InChI=1S/C27H38O4/c1-19(2)9-6-10-20(3)11-7-12-21(4)13-8-14-22(5)15-16-23-17-24(27(30)31)18-25(28)26(23)29/h9,11,13,15,17-18,28-29H,6-8,10,12,14,16H2,1-5H3,(H,30,31)/b20-11+,21-13+,22-15+ | 定義日: | 2019-07-19 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 3,4-bis(oxidanyl)-5-[(2~{E},6~{E},10~{E})-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]benzoic acid |
|
 | L4H | 表記: | farnesyl dihydroxybenzoate | 組成式: | C22 H30 O4 | SMILES: | CC(C)=CCCC(C)=CCCC(C)=CCc1cc(cc(O)c1O)C(O)=O | InChi: | InChI=1S/C22H30O4/c1-15(2)7-5-8-16(3)9-6-10-17(4)11-12-18-13-19(22(25)26)14-20(23)21(18)24/h7,9,11,13-14,23-24H,5-6,8,10,12H2,1-4H3,(H,25,26)/b16-9+,17-11+ | 定義日: | 2019-07-19 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 3,4-bis(oxidanyl)-5-[(2~{E},6~{E})-3,7,11-trimethyldodeca-2,6,10-trienyl]benzoic acid |
|
 | TUY | 表記: | (3S,5S,9R,20R,21R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9,20,
21-pentahydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphadocosan-22-oic acid 3,5-dioxide (non-preferred name) | 組成式: | C25 H40 N7 O21 P3 S | SMILES: | O(P(=O)(O)OCC1C(OP(=O)(O)O)C(O)C(O1)n3cnc2c3ncnc2N)P(OCC(C(C(NCCC(=O)NCCSC(=O)C(C(C(O)=O)O)O)=O)O)(C)C)(O)=O | InChi: | InChI=1S/C25H40N7O21P3S/c1-25(2,18(37)21(38)28-4-3-12(33)27-5-6-57-24(41)15(35)14(34)23(39)40)8-50-56(47,48)53-55(45,46)49-7-11-17(52-54(42,43)44)16(36)22(51-11)32-10-31-13-19(26)29-9-30-20(13)32/h9-11,14-18,22,34-37H,3-8H2,1-2H3,(H,27,33)(H,28,38)(H,39,40)(H,45,46)(H,47,48)(H2,26,29,30)(H2,42,43,44)/t11-,14-,15-,16-,17-,18+,22-/m1/s1 | 別名: | Tartryl-CoA | 定義日: | 2020-04-01 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | (3S,5S,9R,20R,21R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9,20,21-pentahydroxy-8,8-dimethyl-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphadocosan-22-oic acid 3,5-dioxide (non-preferred name) |
|
 | K8N | 表記: | (1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclop
entane-1,2-diol | 組成式: | C22 H23 Br N6 O2 | SMILES: | Nc1nc2cc(CC[CH]3C[CH]([CH](O)[CH]3O)n4ccc5c(N)ncnc45)ccc2cc1Br | InChi: | InChI=1S/C22H23BrN6O2/c23-15-8-12-3-1-11(7-16(12)28-21(15)25)2-4-13-9-17(19(31)18(13)30)29-6-5-14-20(24)26-10-27-22(14)29/h1,3,5-8,10,13,17-19,30-31H,2,4,9H2,(H2,25,28)(H2,24,26,27)/t13-,17+,18+,19-/m0/s1 | 別名: | JNJ45031882 | 定義日: | 2019-05-02 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | (1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol |
|
 | PKB | 表記: | 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-~{N}-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine | 組成式: | C20 H17 F3 N6 O2 | SMILES: | CCOc1ccc2n(ncc2c3ccnc(Nc4cc(OC)cc(c4)C(F)(F)F)n3)n1 | InChi: | InChI=1S/C20H17F3N6O2/c1-3-31-18-5-4-17-15(11-25-29(17)28-18)16-6-7-24-19(27-16)26-13-8-12(20(21,22)23)9-14(10-13)30-2/h4-11H,3H2,1-2H3,(H,24,26,27) | 定義日: | 2020-04-24 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 4-(6-ethoxypyrazolo[1,5-b]pyridazin-3-yl)-~{N}-[3-methoxy-5-(trifluoromethyl)phenyl]pyrimidin-2-amine |
|
 | OSZ | 表記: | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-oxidanylidene-1-piperazin-1-yl-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide | 組成式: | C32 H41 N7 O3 | SMILES: | Nc1n(ncc1C(=O)NCc2ccc(cc2)C(=O)N[CH](CCC3CCCCC3)C(=O)N4CCNCC4)c5ccccc5 | InChi: | InChI=1S/C32H41N7O3/c33-29-27(22-36-39(29)26-9-5-2-6-10-26)31(41)35-21-24-11-14-25(15-12-24)30(40)37-28(16-13-23-7-3-1-4-8-23)32(42)38-19-17-34-18-20-38/h2,5-6,9-12,14-15,22-23,28,34H,1,3-4,7-8,13,16-21,33H2,(H,35,41)(H,37,40)/t28-/m0/s1 | 定義日: | 2020-04-03 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 5-azanyl-~{N}-[[4-[[(2~{S})-4-cyclohexyl-1-oxidanylidene-1-piperazin-1-yl-butan-2-yl]carbamoyl]phenyl]methyl]-1-phenyl-pyrazole-4-carboxamide |
|
 | OUQ | 表記: | (2~{R})-2-(3-fluorophenyl)-5,5-dimethyl-morpholine | 組成式: | C12 H16 F N O | SMILES: | CC1(C)CO[CH](CN1)c2cccc(F)c2 | InChi: | InChI=1S/C12H16FNO/c1-12(2)8-15-11(7-14-12)9-4-3-5-10(13)6-9/h3-6,11,14H,7-8H2,1-2H3/t11-/m0/s1 | 定義日: | 2020-04-06 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | (2~{R})-2-(3-fluorophenyl)-5,5-dimethyl-morpholine |
|
 | OUW | 表記: | ~{N}-methyl-4-(methylamino)pyridine-2-carboxamide | 組成式: | C8 H11 N3 O | SMILES: | CNC(=O)c1cc(NC)ccn1 | InChi: | InChI=1S/C8H11N3O/c1-9-6-3-4-11-7(5-6)8(12)10-2/h3-5H,1-2H3,(H,9,11)(H,10,12) | 定義日: | 2020-04-06 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | ~{N}-methyl-4-(methylamino)pyridine-2-carboxamide |
|
 | OUZ | 表記: | ~{N}-ethyl-2-[(2~{S},5~{R})-5-methyl-2-phenyl-morpholin-4-yl]ethanamine | 組成式: | C15 H24 N2 O | SMILES: | CCNCCN1C[CH](OC[CH]1C)c2ccccc2 | InChi: | InChI=1S/C15H24N2O/c1-3-16-9-10-17-11-15(18-12-13(17)2)14-7-5-4-6-8-14/h4-8,13,15-16H,3,9-12H2,1-2H3/t13-,15-/m1/s1 | 定義日: | 2020-04-06 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | ~{N}-ethyl-2-[(2~{S},5~{R})-5-methyl-2-phenyl-morpholin-4-yl]ethanamine |
|
 | OW8 | 表記: | ~{N}-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxamide | 組成式: | C8 H11 N3 O | SMILES: | CNC(=O)c1n[nH]c2CCCc12 | InChi: | InChI=1S/C8H11N3O/c1-9-8(12)7-5-3-2-4-6(5)10-11-7/h2-4H2,1H3,(H,9,12)(H,10,11) | 定義日: | 2020-04-06 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | ~{N}-methyl-1,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxamide |
|
 | OXB | 表記: | 3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide | 組成式: | C16 H26 N2 O3 S | SMILES: | C[CH]1CO[CH](CN1CCC[S](N)(=O)=O)c2cc(C)ccc2C | InChi: | InChI=1S/C16H26N2O3S/c1-12-5-6-13(2)15(9-12)16-10-18(14(3)11-21-16)7-4-8-22(17,19)20/h5-6,9,14,16H,4,7-8,10-11H2,1-3H3,(H2,17,19,20)/t14-,16-/m0/s1 | 定義日: | 2020-04-07 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide |
|
 | P0B | 表記: | 6-[[(2-chloranyl-6-fluoranyl-phenyl)methyl-methyl-amino]methyl]-1~{H}-pyrimidine-2,4-dione | 組成式: | C13 H13 Cl F N3 O2 | SMILES: | CN(CC1=CC(=O)NC(=O)N1)Cc2c(F)cccc2Cl | InChi: | InChI=1S/C13H13ClFN3O2/c1-18(6-8-5-12(19)17-13(20)16-8)7-9-10(14)3-2-4-11(9)15/h2-5H,6-7H2,1H3,(H2,16,17,19,20) | 定義日: | 2020-04-14 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 6-[[(2-chloranyl-6-fluoranyl-phenyl)methyl-methyl-amino]methyl]-1~{H}-pyrimidine-2,4-dione |
|
 | P0N | 表記: | (2~{R})-2-(2-chlorophenyl)-5,5-dimethyl-morpholine | 組成式: | C12 H16 Cl N O | SMILES: | CC1(C)CO[CH](CN1)c2ccccc2Cl | InChi: | InChI=1S/C12H16ClNO/c1-12(2)8-15-11(7-14-12)9-5-3-4-6-10(9)13/h3-6,11,14H,7-8H2,1-2H3/t11-/m0/s1 | 定義日: | 2020-04-14 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | (2~{R})-2-(2-chlorophenyl)-5,5-dimethyl-morpholine |
|
 | P0Q | 表記: | (2~{R},3~{R})-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholine | 組成式: | C13 H18 Cl N O | SMILES: | C[CH]1NC(C)(C)CO[CH]1c2cccc(Cl)c2 | InChi: | InChI=1S/C13H18ClNO/c1-9-12(16-8-13(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,12,15H,8H2,1-3H3/t9-,12+/m1/s1 | 定義日: | 2020-04-14 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | (2~{R},3~{R})-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholine |
|
 | P0W | 表記: | 6-[[methyl-[(1-phenylpyrazol-3-yl)methyl]amino]methyl]-1~{H}-pyrimidine-2,4-dione | 組成式: | C16 H17 N5 O2 | SMILES: | CN(CC1=CC(=O)NC(=O)N1)Cc2ccn(n2)c3ccccc3 | InChi: | InChI=1S/C16H17N5O2/c1-20(11-13-9-15(22)18-16(23)17-13)10-12-7-8-21(19-12)14-5-3-2-4-6-14/h2-9H,10-11H2,1H3,(H2,17,18,22,23) | 定義日: | 2020-04-14 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 6-[[methyl-[(1-phenylpyrazol-3-yl)methyl]amino]methyl]-1~{H}-pyrimidine-2,4-dione |
|
 | P0Z | 表記: | 3-[(2~{R})-5,5-dimethyl-2-phenyl-morpholin-4-yl]-~{N}-(methylcarbamoyl)propanamide | 組成式: | C17 H25 N3 O3 | SMILES: | CNC(=O)NC(=O)CCN1C[CH](OCC1(C)C)c2ccccc2 | InChi: | InChI=1S/C17H25N3O3/c1-17(2)12-23-14(13-7-5-4-6-8-13)11-20(17)10-9-15(21)19-16(22)18-3/h4-8,14H,9-12H2,1-3H3,(H2,18,19,21,22)/t14-/m0/s1 | 定義日: | 2020-04-14 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 3-[(2~{R})-5,5-dimethyl-2-phenyl-morpholin-4-yl]-~{N}-(methylcarbamoyl)propanamide |
|
 | P1Q | 表記: | 1-[(2~{R},5~{S})-2-(3-chlorophenyl)-5-methyl-morpholin-4-yl]-3-methoxy-propan-2-ol | 組成式: | C15 H22 Cl N O3 | SMILES: | COCC(O)CN1C[CH](OC[CH]1C)c2cccc(Cl)c2 | InChi: | InChI=1S/C15H22ClNO3/c1-11-9-20-15(12-4-3-5-13(16)6-12)8-17(11)7-14(18)10-19-2/h3-6,11,14-15,18H,7-10H2,1-2H3/t11-,14?,15-/m0/s1 | 定義日: | 2020-04-14 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 1-[(2~{R},5~{S})-2-(3-chlorophenyl)-5-methyl-morpholin-4-yl]-3-methoxy-propan-2-ol |
|
 | P5H | 表記: | 6-methyl-~{N}-[2-(methylsulfonylamino)ethyl]-2-oxidanylidene-3~{H}-pyridine-3-carboxamide | 組成式: | C10 H15 N3 O4 S | SMILES: | CC1=NC(=O)[CH](C=C1)C(=O)NCCN[S](C)(=O)=O | InChi: | InChI=1S/C10H15N3O4S/c1-7-3-4-8(10(15)13-7)9(14)11-5-6-12-18(2,16)17/h3-4,8,12H,5-6H2,1-2H3,(H,11,14)/t8-/m0/s1 | 定義日: | 2020-04-15 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 6-methyl-~{N}-[2-(methylsulfonylamino)ethyl]-2-oxidanylidene-3~{H}-pyridine-3-carboxamide |
|
 | P5W | 表記: | 4-[(4-phenyl-1,3-thiazol-2-yl)amino]benzoic acid | 組成式: | C16 H12 N2 O2 S | SMILES: | OC(=O)c1ccc(Nc2scc(n2)c3ccccc3)cc1 | InChi: | InChI=1S/C16H12N2O2S/c19-15(20)12-6-8-13(9-7-12)17-16-18-14(10-21-16)11-4-2-1-3-5-11/h1-10H,(H,17,18)(H,19,20) | 定義日: | 2020-04-16 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | 4-[(4-phenyl-1,3-thiazol-2-yl)amino]benzoic acid |
|
 | MQH | 表記: | Bottromycin A2 | 組成式: | C42 H62 N8 O7 S | SMILES: | COC(=O)C[CH](NC(=O)[CH](NC(=O)[CH](N=C1NCC(=O)N2CC[CH](C)[CH]2C(=O)N[CH](C(C)C)C(=O)N[CH]1C(C)(C)C)C(C)(C)C)[CH](C)c3ccccc3)c4sccn4 | InChi: | InChI=1S/C42H62N8O7S/c1-23(2)30-36(53)49-33(41(5,6)7)35(44-22-28(51)50-19-17-24(3)32(50)38(55)46-30)48-34(42(8,9)10)39(56)47-31(25(4)26-15-13-12-14-16-26)37(54)45-27(21-29(52)57-11)40-43-18-20-58-40/h12-16,18,20,23-25,27,30-34H,17,19,21-22H2,1-11H3,(H,44,48)(H,45,54)(H,46,55)(H,47,56)(H,49,53)/t24-,25+,27-,30+,31+,32+,33-,34-/m1/s1 | 定義日: | 2019-10-21 | 最終更新日: | 2020-07-10 | 公開日: | 2020-07-15 | 識別子(ID): | methyl (3~{R})-3-[[(2~{S},3~{S})-2-[[(2~{S})-2-[(~{E})-[(6~{S},9~{S},12~{S},13~{R})-6-~{tert}-butyl-13-methyl-2,8,11-tris(oxidanylidene)-9-propan-2-yl-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-5-ylidene]amino]-3,3-dimethyl-butanoyl]amino]-3-phenyl-butanoyl]amino]-3-(1,3-thiazol-2-yl)propanoate |
|